Latest filing published 24 Feb 2026 for TELA Bio, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Paul Talmo (senior executive) discloses dealings in TELA Bio, Inc. to SEC (Form 4). We count 19 filings; the first trade dates from 23 February 2022 and the latest from 23 February 2026.
On the market, this insider has only ever bought: 1 purchase, €46k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 18 share grants.
Most recently, on 24 February 2026, the filings show a share grant worth €2,628 in TELA Bio, Inc. The most recent open-market purchase was published on 24 October 2024, 730 days ago. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations